https://www.statnews.com/2025/08/04/vertex-nonopioid-pain-candidate-vx993-fails-phase-2/
0
0
34 words
0
Comments
Vertex Pharmaceuticals said Monday afternoon that its next-generation non-opioid pain reliever failed to significantly outperform placebo in a Phase 2 trial.
You are the first to view
Create an account or login to join the discussion